Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi
admin 9th August 2018 Uncategorised 0Amgen made an aggressive legal bid to push Sanofi and Regeneron’s rival PCSK9 drug off the market when the two were first duking it out in 2014. It didn’t work—but Amgen hasn’t given up. It’s aiming to take the battle to the U.S. Supreme Court instead.
More: Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi
Source: fierce